Clinical Trials
-
Lispro administered by the QS-M Needle-Free Jet Injector generates an earlier insulin exposure
- Published in Expert Opinion Lispro administered by QS-M needle-free injector results in earlier and higher insulin exposure than conventional pen, and a greater early glucose-lowering effect with similar overall potency. ...Read more -
Comparison of jet injector and insulin pen in controlling plasma glucose and insulin concentrations in type 2 diabetic patients
- Published in Medicine Postprandial plasma glucose excursions at the time points of 0.5 to 3 hours were obviously lower in the jet-treated patients than the pen-treated ones (P<0.05). Postprandial plasma insulin levels were markedly higher in the jet-treated patients than the pen-t...Read more -
A prospective, multicenter, randomized, open-label, parallel-group Clinical Trial comparing Patient satisfaction and compliance with a Needle-free Insulin Injector versus conventional insulin pen i...
- Published in Lancet There was no new indurations observed in NIF group compared with IP.(P=0.0150) Broken needle were observed in the IP group, no risk in NIF group. The adjusted mean reduction from baseline of HbA1c 0.55% at week 16 in NFI group was non-inferior and statistically super...Read more